Mechanism based neurotoxicity of mGlu5 positive allosteric modulators – Development challenges for a promising novel antipsychotic target-Reference-Cited by-同舟云学术

Mechanism based neurotoxicity of mGlu5 positive allosteric modulators – Development challenges for a promising novel antipsychotic target

Published:2014-07 Issue: Volume:82 Page:161-173
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Parmentier-Batteur Sophie,Hutson Peter H.,Menzel Karsten,Uslaner Jason M.,Mattson Britta A.,O'Brien Julie A.,Magliaro Brian C.,Forest Thomas,Stump Craig A.,Tynebor Robert M.,Anthony Neville J.,Tucker Thomas J.,Zhang Xu-Fang,Gomez Robert,Huszar Sarah L.,Lambeng Nathalie,Fauré H.,Le Poul Emannuel,Poli Sonia,Rosahl Thomas W.,Rocher Jean-Philippe,Hargreaves Richard,Williams Theresa M.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference54 articles.

1. Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors;Aronica;Mol. Pharmacol,1993

2. Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam;Bagley;Neuroscience,1997

3. Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory;Balschun;Neuroscience,2006

4. Mechanisms of synaptic depression triggered by metabotropic glutamate receptors;Bellone;Cell. Mol. Life Sci.,2008

5. Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine;Camon;J. Neurosci. Res.,1998

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conformational diversity in class C GPCR positive allosteric modulation;2023-11-08

2. GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders;Neuropharmacology;2023-09

3. Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia;CNS Drugs;2022-07-13

4. Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease;Pharmacological Reviews;2022-06-16

5. Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?;Frontiers in Pharmacology;2022-05-11